[e-drug] Phenylbutazone availability

["BIBIANA NJUE" <kndpbn@net2000ke.com>]

E-drug: Phenylbutazone availability
-------------------------------------------------------------------------

Dear colleagues in DRA,

Phenylbutazone has been withdrawn from the market for its known side 
effects since early 1980's.

I would like to know if any Drug Regulatory Authority, has retained it for 
restricted use for a period of not more than seven days.

What is the WHO's updated comments? I have the comments of 1991.

Thank you

DR BIBIANA K. NJUE
HEAD DRUG REGISTRATION
PHARMACY&POISONS BOARD KENYA
P.O BOX 30016 NAIROBI
FAX 254-2-712495
kndpbn@net2000ke.com

[In Norway a patient would be able to get it if the doctor fills in the 
special application form and sends it to the Medicines Control Agency, 
justifying why the patient needs it - and the request is approved. Such an 
application will be valid for one year. To get it reimbursed, you would 
then have to apply to the national insurance authority. KM, co-moderator]

--
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.
Information and archive http://www.healthnet.org/programs/edrug.html
Mail administrative requests to `majordomo@usa.healthnet.org'.
For additional assistance, send mail to:  `owner-e-drug@usa.healthnet.org'.